Tag: Gloria von Geldern

Poster-Programs

Regional MS Summit to Improve Access to High Quality MS Care

Background: In 2006, the Greater Northwest Healthcare Provider Council (HPC) of the National Multiple Sclerosis Society (NMSS) identified a...

Read More

Poster-Disease-modifying Therapy

Real-Life Experience with Ocrelizumab in Older Patients at an Academic MS Center

Background: Ocrelizumab (OCR) is a B-Cell depleting humanized monoclonal antibody FDA-approved for treatment of relapsing remitting...

Read More